David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.73B
| $206K | ﹤0.01% |
+5,043
| New | +$183K |
|
|
CSR
3927
Centerspace
CSR
$917M
| $205K | ﹤0.01% |
+3,399
| New | +$208K |
|
|
RC
3928
Ready Capital
RC
$312M
| $204K | ﹤0.01% |
+46,739
| New | +$207K |
|
|
PCH
3929
PUT
DELISTED
PotlatchDeltic
PCH
| $203K | ﹤0.01% |
+5,300
| New | +$208K |
|
3930
TransUnion
TRU
$16.3B
| $203K | ﹤0.01% |
2,302
-10,005
| -81% | -$834K |
|
3931
Banco Santander Chile
BSAC
$17B
| $202K | ﹤0.01% |
8,025
-235,753
| -97% | -$5.69M |
|
3932
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.71B
| $202K | ﹤0.01% |
+2,148
| New | +$189K |
|
|
CAI
3933
Caris Life Sciences
CAI
$7.38B
| $200K | ﹤0.01% |
+7,500
| New | +$202K |
|
3934
Honda
HMC
$42.3B
| $200K | ﹤0.01% |
+6,941
| New | +$202K |
|
3935
Asure Software
ASUR
$251M
| $199K | ﹤0.01% |
20,361
| – | – |
|
3936
Altimmune
ALT
$605M
| $198K | ﹤0.01% |
51,258
+742
| +1% | +$4.01K |
|
|
DOYU
3937
DouYu International Holdings
DOYU
$128M
| $198K | ﹤0.01% |
30,521
+11,045
| +57% | +$74.7K |
|
|
NOAH
3938
Noah Holdings
NOAH
$597M
| $196K | ﹤0.01% |
16,406
-32,749
| -67% | -$331K |
|
3939
CALL
Hooker Furnishings Corp
HOFT
$152M
| $195K | ﹤0.01% |
+18,400
| New | +$178K |
|
3940
CALL
Spire Global
SPIR
$563M
| $194K | ﹤0.01% |
+16,300
| New | +$164K |
|
|
PDM
3941
Piedmont Realty Trust
PDM
$1.23B
| $193K | ﹤0.01% |
+26,501
| New | +$183K |
|
|
NAMMW
3942
Namib Minerals Warrants
NAMMW
$4.18M
| $193K | ﹤0.01% |
+990,000
| New | +$272K |
|
3943
NCR Voyix
VYX
$1.1B
| $192K | ﹤0.01% |
16,400
-104,439
| -86% | -$1.06M |
|
3944
Cullinan Oncology
CGEM
$1.4B
| $191K | ﹤0.01% |
25,329
-6,165
| -20% | -$49.5K |
|
3945
CALL
UiPath
PATH
$8.59B
| $189K | ﹤0.01% |
+14,800
| New | +$178K |
|
|
JCAP
3946
Jefferson Capital
JCAP
$1.27B
| $185K | ﹤0.01% |
+10,000
| New | +$187K |
|
3947
Magnachip Semiconductor
MX
$116M
| $184K | ﹤0.01% |
+46,164
| New | +$160K |
|
3948
Vir Biotechnology
VIR
$1.68B
| $183K | ﹤0.01% |
36,257
-470,447
| -93% | -$2.52M |
|
3949
Savara
SVRA
$1.14B
| $182K | ﹤0.01% |
79,713
+23,453
| +42% | +$63.8K |
|
|
SA
3950
CALL
Seabridge Gold
SA
$3.56B
| $177K | ﹤0.01% |
+12,200
| New | +$155K |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.